In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority
With more and more research coming out about the harmful effects exposure to toxins during pregnancy can have on the fetus, looking for a well-tested product is more important than ever
Peterson RG, Jackson CV, Zimmerman KM, Alsina-Fernandez J, Michael MD, Emmerson PJ, et al
A provider may find you clinically eligible for semaglutide while your insurer still denies coverage because the diagnosis does not match its criteria
Haugen BR, Alexander EK, Bible KC, et al